Tag | Content |
---|
EnhancerAtlas ID | HS182-19890 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr7:50480140-50480970 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ESRRB | MA0141.3 | chr7:50480898-50480909 | TCAAGGTCATA | + | 6.62 | Esrra | MA0592.2 | chr7:50480897-50480908 | TTCAAGGTCAT | + | 6.62 | Esrrg | MA0643.1 | chr7:50480898-50480908 | TCAAGGTCAT | + | 6.02 | Nr5a2 | MA0505.1 | chr7:50480779-50480794 | CCTGACCTTGAAGCT | - | 6.05 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_09412 | chr7:50468289-50485837 | CD14 | SE_10357 | chr7:50471995-50482114 | CD19_Primary | SE_10918 | chr7:50410368-50486056 | CD20 | SE_61918 | chr7:50458805-50486267 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH07I050412 | chr7 | 50480430 | 50481658 |
|
Enhancer Sequence | AAAAATAAAA AAAGGAAAAA ATAAATCCAT TTTAAGTATA AAGACACATA AGGATTAAAA 60 GTAAAGAAAT TAAGGAAAAA ATACCATAGT TACACTATCA AAAGAAACCT GGAGTAGCTA 120 TACTGATTGA TTTCAGACAC AGCAGAGTCA CAGCAAGCAA AGGCATCAGG GTAAATGGGG 180 GCATTCTATA ATGACACGGG GGTCAATTTT CCAACAAGAT GTAACAATCC TTAGCATGTG 240 CATGCCTAAC AACAGAGCAC CAGCATACAT GAGGCAAAAG CGGAGAGAAC CACACAGAAA 300 TCAATGAACC CACTCCTAGA GCTGGAGACT CCAACATTCC CCATCAGAAA TGGACAGATC 360 CAGCAGGCAG AAAATCAGTA AGGATGTAGT TGAACTGAAA GACAGGAGTT ATTTGGGCAA 420 AGAAAGGCAG CAGACAGTTT CAGGCAGAGG GGGCAGCGTG AATGCGGTAC AGAGGCCTGG 480 ACACGGAATA GTGCTGAAGG AAGGCAAGGC CGTGTGGCTG GGCTGGAGGA GTGTCCTGGG 540 GGCTGGGGAG TGCCAGACGC CTGGAGAGAA GGGGTCCACC ATTCAGCCAA AGAGGTGCCC 600 TCTGAGGGTT GGGGAAGGCA GCAGGAGCTG AGCCCCTGTC CTGACCTTGA AGCTGCAGGG 660 CTGTCATGAA TGCATGGGCC CCCTGAGGAA GGGCGGAGAG GGGTGTGAGC ACCAATTTCA 720 GGTAGTGAAA CTAAGGCCAA GGAAGCAGAG AGCCGTTTTC AAGGTCATAG GGAGTCACCC 780 TCAAGCCACA TTTCCTAAAG CCCATTATGC ATAATGCAAA AAAGGAGAAT 830
|